Forestwalk: A Machine Learning Workflow Brings New Insights Into Posture and Balance in Rodent Beam Walking.

Journal: The European journal of neuroscience
PMID:

Abstract

The beam walk is widely used to study coordination and balance in rodents. While the task has ethological validity, the main endpoints of "foot slip counts" and "time to cross" are prone to human-rater variability and offer limited sensitivity and specificity. We asked if machine learning-based methods could reveal previously hidden, but biologically relevant, insights from the task. Marker-less pose estimation, using DeepLabCut, was deployed to label 13 anatomical key points on mice traversing the beam. Next, we automated classical endpoint detection, including foot slips, with high recall (> 90%) and precision (> 80%). Using data derived from key point tracking, a total of 395 features were engineered and a random forest classifier deployed that, together with skeletal visualizations, could test for group differences and identify determinant features. This workflow, named Forestwalk, uncovered pharmacological treatment effects in C57BL/6J mice, revealed phenotypes in transgenic mice used to study Angelman syndrome and SLC6A1-related neurodevelopmental disorder, and will facilitate a deeper understanding of how the brain controls balance in health and disease.

Authors

  • Francesca Tozzi
    Department of General, HPB Surgery and Liver Transplantation, Ghent University Hospital, Ghent, Belgium.
  • Yan-Ping Zhang
    Department of Mathematics, School of Science, Hebei University of Engineering, Handan 056038, PR China. Electronic address: ping801013@sina.com.
  • Ramanathan Narayanan
    Neuroscience and Rare Diseases Discovery and Translational Area, Roche Pharma Research and Early Development, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Damian Roqueiro
    Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
  • Eoin C O'Connor
    Roche Pharma Research and Early Development, Neuroscience and Rare Diseases, Roche Innovation Center Basel, Basel, Switzerland.